Abacus Life(US:ABL)2025-11-06 22:03Financial Performance - Total revenue for Q3 2025 reached $63.0 million, a 124% increase year-over-year from $28.1 million[3] - GAAP net income attributable to shareholders was $7.1 million, compared to a net loss of $5.1 million in the prior-year period[3] - Adjusted net income increased 60% year-over-year to $23.6 million, with adjusted diluted earnings per share at $0.24[3] - Adjusted EBITDA grew 127% year-over-year to $37.9 million, with an adjusted EBITDA margin of 60.2%[3] - Total revenues for Q3 2025 reached $62.98 million, a significant increase from $28.15 million in Q3 2024, representing a growth of 123.8%[22] - Net income for Q3 2025 was $7.08 million, a turnaround from a net loss of $5.28 million in Q3 2024, reflecting a positive change of $12.36 million[22] - Earnings per share for Q3 2025 were $0.07, compared to a loss of $0.07 per share in Q3 2024, indicating a positive shift in profitability[22] - For the three months ended September 30, 2025, adjusted net income was $23,608,143, compared to $14,719,496 for the same period in 2024, representing a year-over-year increase of 60.5%[23] - Adjusted EPS for the three months ended September 30, 2025, was $0.25 (basic) and $0.24 (diluted), compared to $0.20 (basic) and $0.20 (diluted) in 2024, indicating an increase of 25% in basic EPS[23] - Total revenue for the three months ended September 30, 2025, was $62,975,156, up from $28,148,491 in 2024, reflecting a growth of 123.7%[25] - Adjusted EBITDA for the three months ended September 30, 2025, was $37,904,835, compared to $16,666,306 in 2024, marking a significant increase of 127.6%[25] - The adjusted EBITDA margin for the three months ended September 30, 2025, was 60.2%, compared to 59.2% in 2024, showing a slight improvement[25] - For the nine months ended September 30, 2025, adjusted net income was $54,567,277, compared to $24,118,367 in 2024, representing an increase of 126.5%[24] Asset and Liability Management - The company reported total assets of $918.94 million as of September 30, 2025, up from $874.16 million at the end of 2024, marking an increase of 5.1%[21] - Current liabilities increased to $148.44 million in Q3 2025, compared to $62.47 million in Q4 2024, representing a rise of 137.5%[21] - The company’s total liabilities stood at $479.34 million as of September 30, 2025, compared to $450.87 million at the end of 2024, reflecting an increase of 6.3%[21] - The company’s cash and cash equivalents decreased to $86.42 million as of September 30, 2025, from $131.94 million at the end of 2024, a decline of 34.5%[21] Strategic Initiatives - Abacus completed the strategic acquisition of AccuQuote, enhancing its financial services platform[10] - The company sold $50 million in securitized life insurance assets, structured as an investment-grade rated collateralized note[10] - Abacus was added to the Russell 2000® and 3000® Indexes, effective September 22, 2025, enhancing visibility to institutional investors[10] Return on Investment - Annualized return on invested capital (ROIC) for Q3 2025 was 21% and annualized return on equity (ROE) was 22%[10] - Adjusted annualized ROIC for the period ended September 30, 2025, was 21%, up from 20% in 2024[26] - Adjusted annualized ROE for the period ended September 30, 2025, was 22%, slightly down from 23% in 2024[27] Revenue Breakdown - Life solutions revenue surged to $45.54 million in Q3 2025, compared to $28.03 million in Q3 2024, an increase of 62.6%[22]